Vascular Stent Industry Outlook 2025-2029: Market Set to Cross $25.76 Billion Milestone

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Large Will the Vascular Stent Market Size By 2025?
The size of the vascular stent market has seen a significant increase in recent times. The market is projected to expand from $15.85 billion in 2024 to $17.36 billion in 2025, with a compound annual growth rate (CAGR) of 9.5%. The notable growth during the historic period is linked to factors such as clinical research and development, drug-eluting stents (des), the advent of balloon angioplasty, pioneering stent innovations, and advancements in physician training and skillset.

How Big Is the Vascular Stent Market Size Expected to Grow by 2029?
In the upcoming years, the vascular stent market is set to experience a significant upsurge, reaching a total value of $25.76 billion by the year 2029. This correlates to a compound annual growth rate (CAGR) of 10.4%. The anticipated growth within the predictive timeline is due to factors such as an increased emphasis on preventative cardiovascular treatments, the move to outpatient methods, cost efficiency considerations, advancements in bioabsorbable stents and evolving generation materials, as well as the expansion of endovascular interventions. Holder trends for the forecast period comprise developments in stent coatings and materials, heightened patient education levels and awareness, the transition towards outpatient settings, and an emphasis on cost effectiveness.

View the full report here:
https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Which Key Market Drivers Powering Vascular Stent Market Expansion and Growth?
The future growth of the vascular stent market is expected to be propelled by the increasing prevalence of vascular diseases. These diseases, a subset of cardiovascular diseases (CVD), involve abnormalities in the blood vessels, including the arteries and veins. Vascular stents play a crucial role in treating these conditions by enhancing the delivery of oxygenated blood to the heart. For example, data from the Center for Disease Control and Prevention, a US federal public health agency, revealed that heart disease caused approximately 702,880 deaths in the United States in 2022, accounting for 1 in every 5 deaths. Accordingly, the rising occurrence of cardiovascular diseases (CVDs) will fuel the expansion of the vascular stent market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8363&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Vascular Stent Market?
Rapid technological progress is a significant trend emerging in the vascular stent sector. Numerous firms are investing in state-of-the-art bio-sensing technology, advanced integrated stents, and drug-eluting coronary stent systems to establish a competitive advantage in the industry. For example, in 2022, an Indian medical equipment production company called Translumina launched VIVO ISAR, a cutting-edge dual drug polymer-free coated stent (DDCS). This newest generation stent, which combines safety with effective drug release kinetics, utilizes an antioxidant and lipid-lowering drug called Probucol as a mechanism to release Sirolimus, a medication used to prevent restenosis, thereby achieving a safe and effectual polymer-free DES platform.

What Are the Emerging Segments in the Vascular Stent Market?
The vascular stent market covered in this report is segmented -

1) By Product: Coronary Stents, Peripheral Vascular Stents, Ever Stent Grafts
2) By Type: Bare Metal Stent, Bio-Engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent, Dual Therapy Stent
3) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Polymers Stents
4) By Mode Of Delivery: Balloon-Expandable Stent, Self-Expanding Stent
5) By End-User: Ambulatory Surgical Center, Cardiac Center, Hospital

Subsegments:
1) By Coronary Stents: Drug-Eluting Coronary Stents, Bare Metal Coronary Stents
2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents, Bare Metal Peripheral Stents
3) By EVAR Stent Grafts (Endovascular Aneurysm Repair): Aortoiliac Stent Grafts, Fenestrated Stent Grafts, Branch Stent Grafts

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8363&type=smp

Who Are the Global Leaders in the Vascular Stent Market?
Major companies operating in the vascular stent market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., JOTEC GmbH, W. L. Gore & Associates Inc., MicroPort Scientific Corporation, Translumina GmbH, Lepu Medical Technology Co. Ltd., Purple Medical Solution Pvt. Ltd., Sahajanand Medical Technologies Pvt. Ltd., Stentys SA, Osypka AG, Cook Medical Inc., Cordis Corporation, Endologix Inc., Johnson & Johnson Inc., EP Medsystems Inc.

Which are the Top Profitable Regional Markets for the Vascular Stent Industry?
North America was the largest region in the vascular stent market share in 2024. The regions covered in the vascular stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8363

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.